Metabolite analysis of toosendanin by an ultra-high performance liquid chromatography-quadrupole-time of flight mass spectrometry technique

Molecules

Volumn 18, Issue 10, 2013, Pages 12144-12153

  Wu, Jian Lin ^a   Leung, Elaine Lai Han ^a   Zhou, Hua ^a   Liu, Liang ^a   Li, Na ^a  

^a MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

Human liver microsomes; Metabolites; MS characterization; Toosendanin; UHPLC Q TOF MS

Indexed keywords

HERBACEOUS AGENT; TOOSENDANIN;

DRUG INACTIVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER MICROSOME; METABOLISM; TANDEM MASS SPECTROMETRY; TOXICITY; ARTICLE; DRUG DETOXIFICATION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, CHINESE HERBAL; HUMANS; INACTIVATION, METABOLIC; MICROSOMES, LIVER; TANDEM MASS SPECTROMETRY; METABOLIC DETOXICATION, DRUG;

EID: 84886613530     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules181012144     Document Type: Article

References (16)

1. China Pharmacopoeia Commission. Pharmacopeia of the People's Republic of China; 2010 ed.; Chemical Industry Press: Beijing, China, 2010.
2. Sun, J.; Zhou, H.L. Investigation on clinical application of toosendan fructus. J. Liaoning Univ. Trad. Chin. Med. 2008, 10, 27-28.
3. Fang, X.F.; Cui, Z.J. The anti-botulism triterpenoid toosendanin elicits calcium increase and exocytosis in rat sensory neurons. Cell. Mol. Neurobiol. 2011, 31, 1151-1162.
4. Zhang, B.; Wang, Z.F.; Tang, M.Z.; Shi, Y.L. Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from chinese traditional medicine. Investigat. New Drugs 2005, 23, 547-553.
5. He, Y.; Wang, J.; Liu, X.; Zhang, L.; Yi, G.; Li, C.; He, X.; Wang, P.; Jiang, H. Toosendanin inhibits hepatocellular carcinoma cells by inducing mitochondria-dependent apoptosis. Planta Med. 2010, 76, 1447-1453.
6. Qi, S.Y.; Xiong, Y.H.; Jin, R.M. Time-dose-effect studies on hepatotoxicity of mice induced by fructus toosendan. LiShiZhen Med. Materia Med. Res. 2008, 19, 2694-2696.
7. Xiong, Y.H.; Qi, S.Y.; Jin, R.M.; Chen, D.X.; Huang, Y.W. Time-dose-effect studies on hepatotoxicity of rats induced by fructus toosendan. Jiangsu J. Tradit. Chin. Med. 2008, 40, 83-85.
8. Qi, S.Y.; Jin, R.M.; Liu, H.J.; Huang, Y.W. Mechanism studies on hepatotoxicity of rats induced by fructus toosendan. China J. Chin. Materia Med. 2008, 33, 2045-2047.
9. Zhang, Y.; Qi, X.; Gong, L.; Li, Y.; Liu, L.; Xue, X.; Xiao, Y.; Wu, X.; Ren, J. Roles of reactive oxygen species and map kinases in the primary rat hepatocytes death induced by toosendanin. Toxicology 2008, 249, 62-68.
10. Wang, X.; Wang, C.; Wang, Z. Determination of toosendanin in rat plasma by ultra-performance liquid chromatography-electrospray ionization-mass spectrometry and its application in a pharmacokinetic study. Biomed. Chromatogr. 2013, 27, 222-227.
11. Xie, C.; Zhong, D.F.; Yu, K.; Chen, X.Y. Recent advances in metabolite identification. Bioanaysis 2012, 4, 937-959.
12. Ong, E.S.; Ong, C.N. Qualitative and quantitative analysis of toosendanin in Melia toosendan Sieb. Et Zucc (Meliaceae) with liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2007, 21, 589-598.
13. Ramanathan, R.; Comezoglu, S.N.; Humphreys, W.G. Metabolite identification strategies and procedures. In Using Mass Spectrometry for Drug Metabolism Studies, 2nd ed.; Korfmacher, W.A., Eds.; CRC Press: Boca Raton, Florida, USA, 2010; pp. 127-203.
14. Chen, L.J.; DeRose, E.F.; Burka, L.T. Metabolism of furans in vitro ipomeanine and 4-ipomeanol. Chem. Res. Toxicol. 2006, 19, 1320-1329.
15. Peterson, L.A. Reactive metabolites in the biotransformation of molecules containing a furan ring. Chem. Res. Toxicol. 2012, 26, 6-25.
16. Dalvie, D.K.; Kalgutkar, A.S.; Khojasteh-Bakht, S.C.; Obach, R.S.; O'Donnell, J.P. Biotransformation reactions of five-membered aromatic heterocyclic rings. Chem. Res. Toxicol. 2002, 15, 269-299.